These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3030346)

  • 1. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N; Harada S; Nakashima H
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
    Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
    Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line.
    Imai H; Ikuta K; Ueda S; Suehiro S; Yamamoto N; Kato S
    Jpn J Cancer Res; 1987 Jul; 78(7):648-50. PubMed ID: 3114194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
    Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
    Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
    Matsushita S; Mitsuya H; Reitz MS; Broder S
    J Clin Invest; 1987 Aug; 80(2):394-400. PubMed ID: 3038956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
    Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.
    Ikuta K; Imai H; Ueda S; Suehiro S; Yamamoto N; Kato S
    Jpn J Cancer Res; 1987 Jul; 78(7):643-7. PubMed ID: 3114193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of antiviral activity and mechanism of action of zidovudine. An overview.
    Furman PA; Barry DW
    Am J Med; 1988 Aug; 85(2A):176-81. PubMed ID: 3044082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells.
    Nakashima H; Harada S; Yamamoto N
    Med Microbiol Immunol; 1987; 176(4):189-98. PubMed ID: 2441239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of phorbol ester derivates on human immunodeficiency virus 1 replication in lymphocytic and monocytic human cells.
    Kalvatchev Z; Walder R; Garzaro D
    Acta Virol; 1997 Oct; 41(5):289-92. PubMed ID: 9607083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
    Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
    Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro.
    Kuno S; Ueno R; Hayaishi O; Nakashima H; Harada S; Yamamoto N
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3487-90. PubMed ID: 3010301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
    Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
    Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
    Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS studies in Japan.
    Harada S; Yamamoto N
    Jpn J Cancer Res; 1987 May; 78(5):415-27. PubMed ID: 3112053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.